バイオイメージング市場：技術、製品、モダリティ、用途、エンドユーザー別-2025-2030年の世界予測

バイオイメージング市場の2024年の市場規模は67億米ドルで、2025年には73億8,000万米ドル、CAGR 10.23%で成長し、2030年には120億3,000万米ドルに達すると予測されています。

バイオイメージングは医療イノベーションの結節点にあり、臨床医や研究者が生体内部構造を視覚化する方法を変革する強力なツールを提供しています。急速に発展する今日の科学環境において、画像技術は診断、治療計画、画期的な研究に不可欠です。センサー技術、データ処理、画像処理ソフトウェアにおける最近の進歩は、病気の検出とモニタリングの精度を高め、臨床と研究の両方の場面で大きな飛躍を遂げています。

工学的能力と生物学的洞察力の融合は、診断精度を向上させるだけでなく、侵襲性を低減させる革新的なイメージング・ソリューションへの道を開いた。イメージング・システムがより洗練されるにつれて、エンドユーザーはより高い信頼性と正確性をもって意思決定できるようになります。このイントロダクションでは、バイオイメージング分野の軌跡を決定付けている変革的シフト、セグメンテーション要因、地域ダイナミクス、競合情勢について深く掘り下げます。

これらの側面を探っていくと、この分野が単に単独で進化しているのではなく、ヘルスケアにおける長年の課題に対処するために、分野横断的なイノベーションを急速に統合していることが明らかになります。データに裏打ちされ、イノベーションに牽引されるバイオイメージングは、伝統的な診断手法と現代技術の飛躍的進歩を融合させることでその影響力を拡大し続け、最終的には患者ケアと生物医学研究へのアプローチ方法を再構築しています。

バイオイメージング分野を形成する変革的シフト

バイオイメージングの情勢は、技術的ブレークスルーが新たな臨床要件と融合するにつれて劇的な変貌を遂げつつあります。この変革の特徴は、能力を拡大し、精度を高め、操作の複雑さを軽減するイノベーションの融合です。画像診断における人工知能、高度なコンピューティング技術、自動化の急速な統合は、画像の取得と解析のペースを加速させただけでなく、様々な用途に必要とされる解釈精度を向上させました。

最も注目すべきシフトの一つは、異なる画像モダリティを融合して生物学的プロセスの包括的なビューを提供するハイブリッド画像システムの出現です。堅牢なデータ解析に支えられたこれらのシステムは、臨床医に微妙な異常の検出において比類ない精度を提供します。最近のハードウェアの小型化とセンサ感度の向上により、より鮮明で詳細な画像が得られるようになり、疾患の早期発見や微妙な治療介入に大きく貢献しています。

さらに、画像処理ソフトウエアの進化は、医師が大規模なデータセットを管理し、実用的な知見を抽出する方法を再定義しました。洗練されたアルゴリズムと強化された画像解析ツールにより、異常の詳細な定量化と、経時的な疾患進行の追跡が可能になりました。このような変革的シフトが業界の力学を再定義し続ける中、利害関係者は急速に進化する市場で競争力を維持するためにイノベーションを取り入れることが推奨されます。

バイオイメージングの包括的なセグメンテーション洞察

バイオイメージング市場は、このダイナミックな分野を牽引する技術、製品、モダリティ、アプリケーション、エンドユーザーの多様性を反映して、複雑にセグメント化されています。技術的側面を考慮すると、調査は複数のイメージング手法にまたがるのが常です。市場は、内視鏡、磁気共鳴画像、核画像、手術用顕微鏡、超音波、X線画像などの先端分野にわたって調査されています。この技術的セグメンテーションにより、各モダリティが診断精度にどのように寄与しているかについての微妙な理解が得られ、目標とする技術革新の指針となります。

これと並行して、製品のセグメンテーションは、イメージング・システム、機器、試薬、ソフトウェアといった明確なカテゴリーに広がっています。機器のカテゴリーでは、CTスキャナー、MRI装置、超音波診断装置が特に注目され、これらの技術が現代の医療診断において極めて重要な役割を果たしていることが強調されています。同様に、ソフトウェア分野はデータ管理システムと画像解析ツールに二分され、いずれも複雑な画像データの処理と解釈に役立っています。

さらに、モダリティに基づくセグメンテーションでは、2Dイメージングと3Dイメージングを区別し、より没入型の診断・治療技術への移行に光を当てています。アプリケーション領域では、臨床診断、創薬、調査、治療など幅広い領域を調査しており、臨床と実験の両方の場面でバイオイメージングが多面的に応用されていることを強調しています。最後に、外来手術センターから画像診断センター、さらには病院や診療所まで、エンドユーザーに焦点を当てる。各セグメンテーションは、バイオイメージング市場の詳細なパノラマを提供し、進化動向、投資見通し、利害関係者への技術革新の機会に関する洞察を提供します。

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 慢性疾患および神経疾患の有病率の増加
    • 非侵襲的診断法への世界の移行
    • ヘルスケア費の増加とヘルスケアインフラへの投資
  • 抑制要因
    • バイオイメージングデバイスおよびシステムの厳格な規制基準と相互運用性の問題
  • 機会
    • ポイントオブケア環境での使用に適したポータブルで手頃な価格のバイオイメージングデバイスの開発
    • 神経学および腫瘍学分野におけるバイオイメージングアプリケーションの拡大
  • 課題
    • バイオイメージングデータの使用に関連する倫理およびプライバシーに関する懸念
• 市場セグメンテーション分析
  • 技術：手頃な価格と非イオン化の性質により超音波が好まれる傾向が高まっている
  • エンドユーザー：診断画像センターによるバイオイメージングの利用拡大
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社会
  • 技術的
  • 法律上
  • 環境

第6章 バイオイメージング市場：技術別

• 内視鏡検査
• 磁気共鳴画像法
• 核イメージング
• 外科用顕微鏡
• 超音波
• X線画像

第7章 バイオイメージング市場：製品別

• イメージングシステム
• 機器
  • CTスキャナー
  • MRI装置
  • 超音波装置
• 試薬
• ソフトウェア
  • データ管理ソフトウェア
  • 画像解析ソフトウェア

第8章 バイオイメージング市場：モダリティ別

• 2Dイメージング
• 3Dイメージング

第9章 バイオイメージング市場：用途別

• 臨床診断
• 創薬
• 調査
• 治療薬

第10章 バイオイメージング市場：エンドユーザー別

• 外来手術センター
• 診断画像センター
• 病院と診療所

第11章 南北アメリカのバイオイメージング市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第12章 アジア太平洋地域のバイオイメージング市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第13章 欧州・中東・アフリカのバイオイメージング市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第14章 競合情勢

• 市場シェア分析, 2024
• FPNVポジショニングマトリックス, 2024
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• BaySpec, Inc.
• Bracco S.p.A.
• Bruker Corporation
• Canon Medical Systems Corporation
• Digirad Corporation
• Esaote S.p.A
• Fujifilm Holdings Corporation
• GE HealthCare Technologies, Inc.
• Hitachi Medical Corporation
• HT BioImaging Ltd
• iThera Medical GmbH
• Kitware, Inc.
• Koninklijke Philips N.V.
• Lantheus Medical Imaging, Inc.
• M Squared Lasers Ltd.
• MARS Bioimaging Limited
• Medtronic PLC
• MobileODT Ltd by Liger Medical LLC
• Perspectum Ltd.
• Quibim, S.L.
• RadNet, Inc.
• Rivanna Medical, Inc.
• Samsung Medison Co., Ltd.
• Siemens Healthineers

LIST OF FIGURES

• FIGURE 1. BIO-IMAGING MARKET MULTI-CURRENCY
• FIGURE 2. BIO-IMAGING MARKET MULTI-LANGUAGE
• FIGURE 3. BIO-IMAGING MARKET RESEARCH PROCESS
• FIGURE 4. BIO-IMAGING MARKET SIZE, 2024 VS 2030
• FIGURE 5. GLOBAL BIO-IMAGING MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 6. GLOBAL BIO-IMAGING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 7. GLOBAL BIO-IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
• FIGURE 9. GLOBAL BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL BIO-IMAGING MARKET SIZE, BY PRODUCT, 2024 VS 2030 (%)
• FIGURE 11. GLOBAL BIO-IMAGING MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL BIO-IMAGING MARKET SIZE, BY MODALITY, 2024 VS 2030 (%)
• FIGURE 13. GLOBAL BIO-IMAGING MARKET SIZE, BY MODALITY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 14. GLOBAL BIO-IMAGING MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
• FIGURE 15. GLOBAL BIO-IMAGING MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 16. GLOBAL BIO-IMAGING MARKET SIZE, BY END USER, 2024 VS 2030 (%)
• FIGURE 17. GLOBAL BIO-IMAGING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 18. AMERICAS BIO-IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 19. AMERICAS BIO-IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 20. UNITED STATES BIO-IMAGING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
• FIGURE 21. UNITED STATES BIO-IMAGING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 22. ASIA-PACIFIC BIO-IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 23. ASIA-PACIFIC BIO-IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 24. EUROPE, MIDDLE EAST & AFRICA BIO-IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 25. EUROPE, MIDDLE EAST & AFRICA BIO-IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 26. BIO-IMAGING MARKET SHARE, BY KEY PLAYER, 2024
• FIGURE 27. BIO-IMAGING MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

• TABLE 1. BIO-IMAGING MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
• TABLE 3. GLOBAL BIO-IMAGING MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL BIO-IMAGING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL BIO-IMAGING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. BIO-IMAGING MARKET DYNAMICS
• TABLE 7. GLOBAL BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL BIO-IMAGING MARKET SIZE, BY ENDOSCOPY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL BIO-IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL BIO-IMAGING MARKET SIZE, BY NUCLEAR IMAGING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL BIO-IMAGING MARKET SIZE, BY SURGICAL MICROSCOPY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL BIO-IMAGING MARKET SIZE, BY ULTRASOUND, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL BIO-IMAGING MARKET SIZE, BY X-RAY IMAGING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL BIO-IMAGING MARKET SIZE, BY IMAGING SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL BIO-IMAGING MARKET SIZE, BY CT SCANNERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL BIO-IMAGING MARKET SIZE, BY MRI MACHINES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL BIO-IMAGING MARKET SIZE, BY ULTRASOUND DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL BIO-IMAGING MARKET SIZE, BY REAGENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL BIO-IMAGING MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL BIO-IMAGING MARKET SIZE, BY DATA MANAGEMENT SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL BIO-IMAGING MARKET SIZE, BY IMAGE ANALYSIS SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL BIO-IMAGING MARKET SIZE, BY 2D IMAGING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL BIO-IMAGING MARKET SIZE, BY 3D IMAGING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL BIO-IMAGING MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL BIO-IMAGING MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 32. GLOBAL BIO-IMAGING MARKET SIZE, BY RESEARCH, BY REGION, 2018-2030 (USD MILLION)
• TABLE 33. GLOBAL BIO-IMAGING MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 34. GLOBAL BIO-IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 35. GLOBAL BIO-IMAGING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 36. GLOBAL BIO-IMAGING MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 37. GLOBAL BIO-IMAGING MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 38. AMERICAS BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 39. AMERICAS BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 40. AMERICAS BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 41. AMERICAS BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 42. AMERICAS BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 43. AMERICAS BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 44. AMERICAS BIO-IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 45. AMERICAS BIO-IMAGING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 46. ARGENTINA BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 47. ARGENTINA BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 48. ARGENTINA BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 49. ARGENTINA BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 50. ARGENTINA BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 51. ARGENTINA BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 52. ARGENTINA BIO-IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 53. BRAZIL BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 54. BRAZIL BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 55. BRAZIL BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 56. BRAZIL BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 57. BRAZIL BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 58. BRAZIL BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 59. BRAZIL BIO-IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 60. CANADA BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 61. CANADA BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 62. CANADA BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 63. CANADA BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 64. CANADA BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 65. CANADA BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 66. CANADA BIO-IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 67. MEXICO BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 68. MEXICO BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 69. MEXICO BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 70. MEXICO BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 71. MEXICO BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 72. MEXICO BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 73. MEXICO BIO-IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 74. UNITED STATES BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 75. UNITED STATES BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 76. UNITED STATES BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 77. UNITED STATES BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 78. UNITED STATES BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 79. UNITED STATES BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 80. UNITED STATES BIO-IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 81. UNITED STATES BIO-IMAGING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 82. ASIA-PACIFIC BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 83. ASIA-PACIFIC BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 84. ASIA-PACIFIC BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 85. ASIA-PACIFIC BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 86. ASIA-PACIFIC BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 87. ASIA-PACIFIC BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 88. ASIA-PACIFIC BIO-IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 89. ASIA-PACIFIC BIO-IMAGING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 90. AUSTRALIA BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 91. AUSTRALIA BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 92. AUSTRALIA BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 93. AUSTRALIA BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 94. AUSTRALIA BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 95. AUSTRALIA BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 96. AUSTRALIA BIO-IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 97. CHINA BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 98. CHINA BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 99. CHINA BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 100. CHINA BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 101. CHINA BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 102. CHINA BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 103. CHINA BIO-IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 104. INDIA BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 105. INDIA BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 106. INDIA BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 107. INDIA BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 108. INDIA BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 109. INDIA BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 110. INDIA BIO-IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 111. INDONESIA BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 112. INDONESIA BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 113. INDONESIA BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 114. INDONESIA BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 115. INDONESIA BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 116. INDONESIA BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 117. INDONESIA BIO-IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 118. JAPAN BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 119. JAPAN BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 120. JAPAN BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 121. JAPAN BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 122. JAPAN BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 123. JAPAN BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 124. JAPAN BIO-IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 125. MALAYSIA BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 126. MALAYSIA BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 127. MALAYSIA BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 128. MALAYSIA BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 129. MALAYSIA BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 130. MALAYSIA BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 131. MALAYSIA BIO-IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 132. PHILIPPINES BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 133. PHILIPPINES BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 134. PHILIPPINES BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 135. PHILIPPINES BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 136. PHILIPPINES BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 137. PHILIPPINES BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 138. PHILIPPINES BIO-IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 139. SINGAPORE BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 140. SINGAPORE BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 141. SINGAPORE BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 142. SINGAPORE BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 143. SINGAPORE BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 144. SINGAPORE BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 145. SINGAPORE BIO-IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 146. SOUTH KOREA BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 147. SOUTH KOREA BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 148. SOUTH KOREA BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 149. SOUTH KOREA BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 150. SOUTH KOREA BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 151. SOUTH KOREA BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 152. SOUTH KOREA BIO-IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 153. TAIWAN BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 154. TAIWAN BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 155. TAIWAN BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 156. TAIWAN BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 157. TAIWAN BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 158. TAIWAN BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 159. TAIWAN BIO-IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 160. THAILAND BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 161. THAILAND BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 162. THAILAND BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 163. THAILAND BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 164. THAILAND BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 165. THAILAND BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 166. THAILAND BIO-IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 167. VIETNAM BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 168. VIETNAM BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 169. VIETNAM BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 170. VIETNAM BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 171. VIETNAM BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 172. VIETNAM BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 173. VIETNAM BIO-IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 174. EUROPE, MIDDLE EAST & AFRICA BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 175. EUROPE, MIDDLE EAST & AFRICA BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 176. EUROPE, MIDDLE EAST & AFRICA BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 177. EUROPE, MIDDLE EAST & AFRICA BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 178. EUROPE, MIDDLE EAST & AFRICA BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 179. EUROPE, MIDDLE EAST & AFRICA BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 180. EUROPE, MIDDLE EAST & AFRICA BIO-IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 181. EUROPE, MIDDLE EAST & AFRICA BIO-IMAGING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 182. DENMARK BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 183. DENMARK BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 184. DENMARK BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 185. DENMARK BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 186. DENMARK BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 187. DENMARK BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 188. DENMARK BIO-IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 189. EGYPT BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 190. EGYPT BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 191. EGYPT BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 192. EGYPT BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 193. EGYPT BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 194. EGYPT BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 195. EGYPT BIO-IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 196. FINLAND BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 197. FINLAND BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 198. FINLAND BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 199. FINLAND BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 200. FINLAND BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 201. FINLAND BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 202. FINLAND BIO-IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 203. FRANCE BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 204. FRANCE BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 205. FRANCE BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 206. FRANCE BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 207. FRANCE BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 208. FRANCE BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 209. FRANCE BIO-IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 210. GERMANY BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 211. GERMANY BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 212. GERMANY BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 213. GERMANY BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 214. GERMANY BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 215. GERMANY BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 216. GERMANY BIO-IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 217. ISRAEL BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 218. ISRAEL BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 219. ISRAEL BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 220. ISRAEL BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 221. ISRAEL BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 222. ISRAEL BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 223. ISRAEL BIO-IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 224. ITALY BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 225. ITALY BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 226. ITALY BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 227. ITALY BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 228. ITALY BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 229. ITALY BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 230. ITALY BIO-IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 231. NETHERLANDS BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 232. NETHERLANDS BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 233. NETHERLANDS BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 234. NETHERLANDS BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 235. NETHERLANDS BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 236. NETHERLANDS BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 237. NETHERLANDS BIO-IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 238. NIGERIA BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 239. NIGERIA BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 240. NIGERIA BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 241. NIGERIA BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 242. NIGERIA BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 243. NIGERIA BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 244. NIGERIA BIO-IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 245. NORWAY BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 246. NORWAY BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 247. NORWAY BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 248. NORWAY BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 249. NORWAY BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 250. NORWAY BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 251. NORWAY BIO-IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 252. POLAND BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 253. POLAND BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 254. POLAND BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 255. POLAND BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 256. POLAND BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 257. POLAND BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 258. POLAND BIO-IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 259. QATAR BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 260. QATAR BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 261. QATAR BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 262. QATAR BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 263. QATAR BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 264. QATAR BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 265. QATAR BIO-IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 266. RUSSIA BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 267. RUSSIA BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 268. RUSSIA BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 269. RUSSIA BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 270. RUSSIA BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 271. RUSSIA BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 272. RUSSIA BIO-IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 273. SAUDI ARABIA BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 274. SAUDI ARABIA BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 275. SAUDI ARABIA BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 276. SAUDI ARABIA BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 277. SAUDI ARABIA BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 278. SAUDI ARABIA BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 279. SAUDI ARABIA BIO-IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 280. SOUTH AFRICA BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 281. SOUTH AFRICA BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 282. SOUTH AFRICA BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 283. SOUTH AFRICA BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 284. SOUTH AFRICA BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 285. SOUTH AFRICA BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 286. SOUTH AFRICA BIO-IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 287. SPAIN BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 288. SPAIN BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 289. SPAIN BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 290. SPAIN BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 291. SPAIN BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 292. SPAIN BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 293. SPAIN BIO-IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 294. SWEDEN BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 295. SWEDEN BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 296. SWEDEN BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 297. SWEDEN BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 298. SWEDEN BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 299. SWEDEN BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 300. SWEDEN BIO-IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 301. SWITZERLAND BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 302. SWITZERLAND BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 303. SWITZERLAND BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 304. SWITZERLAND BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 305. SWITZERLAND BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 306. SWITZERLAND BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 307. SWITZERLAND BIO-IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 308. TURKEY BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 309. TURKEY BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 310. TURKEY BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 311. TURKEY BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 312. TURKEY BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 313. TURKEY BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 314. TURKEY BIO-IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 315. UNITED ARAB EMIRATES BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 316. UNITED ARAB EMIRATES BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 317. UNITED ARAB EMIRATES BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 318. UNITED ARAB EMIRATES BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 319. UNITED ARAB EMIRATES BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 320. UNITED ARAB EMIRATES BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 321. UNITED ARAB EMIRATES BIO-IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 322. UNITED KINGDOM BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 323. UNITED KINGDOM BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 324. UNITED KINGDOM BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 325. UNITED KINGDOM BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 326. UNITED KINGDOM BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
• TABLE 327. UNITED KINGDOM BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 328. UNITED KINGDOM BIO-IMAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 329. BIO-IMAGING MARKET SHARE, BY KEY PLAYER, 2024
• TABLE 330. BIO-IMAGING MARKET, FPNV POSITIONING MATRIX, 2024

The Bio-imaging Market was valued at USD 6.70 billion in 2024 and is projected to grow to USD 7.38 billion in 2025, with a CAGR of 10.23%, reaching USD 12.03 billion by 2030.

Bio-imaging is at the nexus of medical innovation, providing powerful tools that have transformed the way clinicians and researchers visualize internal biological structures. In today's fast-evolving scientific environment, imaging technologies are integral to diagnosis, treatment planning, and breakthrough research. Recent advances in sensor technology, data processing, and imaging software have elevated the precision of disease detection and monitoring, marking a significant leap forward in both clinical and research settings.

The convergence of engineering prowess with biological insights has paved the way for innovative imaging solutions that not only improve diagnostic accuracy but also reduce invasiveness. As imaging systems become more sophisticated, they empower end-users to make decisions with greater confidence and accuracy. This initial introduction sets the stage for a deep dive into the transformative shifts, segmentation factors, regional dynamics, and competitive landscape that are defining the trajectory of the bio-imaging arena.

As we explore these facets, it becomes evident that the sector is not merely evolving in isolation; it is rapidly integrating cross-disciplinary innovations to address longstanding challenges in healthcare. Grounded in data and driven by innovation, bio-imaging continues to expand its influence by merging traditional diagnostic practices with modern technological breakthroughs, ultimately reshaping the way we approach patient care and biomedical research.

Transformative Shifts Reshaping the Bio-Imaging Sector

The landscape of bio-imaging is undergoing dramatic transformation as technological breakthroughs converge with new clinical requirements. This transformation is characterized by an amalgamation of innovations that expand capabilities, refine accuracy, and reduce operational complexity. The rapid integration of artificial intelligence, advanced computing techniques, and automation in imaging has not only accelerated the pace at which images are acquired and analyzed but has also enhanced the interpretative accuracy required for a wide variety of applications.

One of the most notable shifts is the emergence of hybrid imaging systems that merge different imaging modalities to provide comprehensive views of biological processes. These systems, supported by robust data analytics, offer clinicians unparalleled precision in detecting subtle anomalies. Recent improvements in hardware miniaturization and sensor sensitivity allow for clearer, more detailed images that contribute significantly to early disease detection and nuanced therapeutic interventions.

Furthermore, the evolution within imaging software has redefined how practitioners manage large datasets and extract actionable insights. Refined algorithms and enhanced image analysis tools enable the detailed quantification of abnormalities and the tracking of disease progression over time. As these transformative shifts continue to redefine industry dynamics, stakeholders are encouraged to embrace innovation to maintain their competitive edge in a rapidly evolving market.

Comprehensive Segmentation Insights in Bio-Imaging

The bio-imaging market is intricately segmented, reflecting the diversity of technologies, products, modalities, applications, and end users that drive this dynamic field. When considering technological aspects, research regularly spans across multiple imaging methods. The market is studied across advanced areas such as endoscopy, magnetic resonance imaging, nuclear imaging, surgical microscopy, ultrasound, and x-ray imaging. This technological segmentation provides a nuanced understanding of how each modality contributes to diagnostic precision and guides targeted innovation.

In parallel, the product segmentation extends into distinct categories such as imaging systems, instruments, reagents, and software. Within the instruments category, particular attention is given to CT scanners, MRI machines, and ultrasound devices, all of which underscore the pivotal role these technologies play in modern medical diagnostics. Similarly, the software segment is bifurcated into data management systems and image analysis tools, both of which are instrumental in processing and interpreting complex imaging data.

Furthermore, segmentation based on modality distinguishes between 2D imaging and 3D imaging, shedding light on the transition towards more immersive diagnostic and therapeutic techniques. Within the application domain, the market examines a wide spectrum that includes clinical diagnostics, drug discovery, research, and therapeutics, highlighting the multifaceted applications of bio-imaging in both clinical and experimental settings. Lastly, a keen focus is placed on the end users, which range from ambulatory surgical centers to diagnostic imaging centers, and extend into hospitals and clinics. Each segmentation component contributes collectively to a detailed panorama of the bio-imaging market, offering insights into evolution trends, investment prospects, and innovation opportunities for stakeholders.

Based on Technology, market is studied across Endoscopy, Magnetic Resonance Imaging, Nuclear Imaging, Surgical Microscopy, Ultrasound, and X-ray Imaging.

Based on Product, market is studied across Imaging Systems, Instruments, Reagents, and Software. The Instruments is further studied across CT Scanners, MRI Machines, and Ultrasound Devices. The Software is further studied across Data Management Software and Image Analysis Software.

Based on Modality, market is studied across 2D Imaging and 3D Imaging.

Based on Application, market is studied across Clinical Diagnostics, Drug Discovery, Research, and Therapeutics.

Based on End User, market is studied across Ambulatory Surgical Centers, Diagnostic Imaging Centers, and Hospitals & Clinics.

Strategic Regional Insights in Global Bio-Imaging Markets

The evolution of bio-imaging is not just a product of technological advance; it is also shaped by regional dynamics that influence investment, market penetration, and regulatory frameworks. A thorough exploration of the market reveals distinctive trends across major regions. In the Americas, robust healthcare infrastructure coupled with aggressive adoption of advanced technologies fosters an environment ripe for innovation. This region benefits from substantial research investments and a strong network of academic institutions that often pioneer breakthroughs in imaging technology.

Transitioning to regions that encompass Europe, the Middle East, and Africa, the focus is on a blend of longstanding medical expertise and emerging markets. These regions offer a strategic balance where established healthcare systems merge with the need for innovation-driven growth. Regulatory frameworks in these regions are evolving, thus creating pathways for novel imaging modalities to integrate seamlessly with traditional practices while ensuring compliance and patient safety.

In the Asia-Pacific region, rapid urbanization, increased healthcare spending, and expanding medical infrastructure position it as a lucrative market for bio-imaging innovations. The region is experiencing swift technological adoption and a reimagining of traditional diagnostic practices, which leads to enhanced service delivery and competitive advancements. The interplay of these regional insights not only informs localized strategies but also provides a broader understanding of the global momentum driving the bio-imaging industry.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Competitive Landscape: Key Companies Driving Innovation

A competitive analysis of the bio-imaging market reveals a landscape populated by a diverse set of players, each contributing to technological breakthroughs and market expansion. Prominent companies including BaySpec, Inc. and Bracco S.p.A. demonstrate a commitment to quality and innovation that has helped set industry benchmarks. These firms, together with Bruker Corporation and Canon Medical Systems Corporation, are instrumental in pushing the envelope of imaging technologies, ensuring that state-of-the-art systems meet current clinical needs.

Further reinforcing industry dynamism are organizations such as Digirad Corporation, Esaote S.p.A., and Fujifilm Holdings Corporation, which have carved niches in niche areas ranging from advanced imaging systems to specialized reagents. GE HealthCare Technologies, Inc. and Hitachi Medical Corporation continue to be pioneering figures in elevating imaging capabilities with their extensive research and development initiatives. HT BioImaging Ltd and iThera Medical GmbH also showcase their prowess in combining research-grade technologies with practical applications to enhance diagnostic accuracy.

Additional market influencers such as Kitware, Inc., Koninklijke Philips N.V., and Lantheus Medical Imaging, Inc. remain at the forefront of software-driven imaging innovations, complemented by M Squared Lasers Ltd. and MARS Bioimaging Limited, who contribute through precision hardware innovations. Medtronic PLC and MobileODT Ltd by Liger Medical LLC further exemplify the entrepreneurial spirit in this sector, leveraging cutting-edge technology to redefine patient imaging protocols. Industry specialists including Perspectum Ltd., Quibim, S.L., RadNet, Inc., and Rivanna Medical, Inc. maintain high standards in imaging performance, while Samsung Medison Co., Ltd. and Siemens Healthineers are recognized globally for their comprehensive healthcare solutions. Together, these companies form a robust network of innovators whose contributions are indispensable in driving the bio-imaging field toward a future of enhanced diagnostic and therapeutic performance.

The report delves into recent significant developments in the Bio-imaging Market, highlighting leading vendors and their innovative profiles. These include BaySpec, Inc., Bracco S.p.A., Bruker Corporation, Canon Medical Systems Corporation, Digirad Corporation, Esaote S.p.A, Fujifilm Holdings Corporation, GE HealthCare Technologies, Inc., Hitachi Medical Corporation, HT BioImaging Ltd, iThera Medical GmbH, Kitware, Inc., Koninklijke Philips N.V., Lantheus Medical Imaging, Inc., M Squared Lasers Ltd., MARS Bioimaging Limited, Medtronic PLC, MobileODT Ltd by Liger Medical LLC, Perspectum Ltd., Quibim, S.L., RadNet, Inc., Rivanna Medical, Inc., Samsung Medison Co., Ltd., and Siemens Healthineers. Strategic Recommendations for Navigating the Bio-Imaging Market

Industry leaders are encouraged to adopt a multipronged strategy that emphasizes continued investment in research and development, collaboration across disciplines, and an agile response to regulatory changes. It is imperative that decision-makers harness the potential of advanced analytics and artificial intelligence to process the ever-growing volume of imaging data. By integrating data-driven insights into strategic planning, companies can preemptively address market shifts and tailor their product portfolios to meet evolving clinical needs.

To remain competitive, companies should prioritize partnerships that bridge the gap between engineering innovations and biological applications. Engaging in joint ventures or collaborations with academic institutions and research organizations can facilitate access to cutting-edge technologies and foster a culture of continuous improvement. Furthermore, adopting a global perspective that accounts for regional variances in healthcare infrastructure and regulatory environments will enhance a company's ability to customize solutions to local market demands.

Leaders would also benefit from streamlining operational workflows and investing in digital transformation initiatives that drive efficiency. This includes enhancing cybersecurity protocols and ensuring robust data governance to protect sensitive patient information. Ultimately, a forward-thinking approach that balances innovation with operational excellence will be key to harnessing the full potential of the bio-imaging market.

Conclusion: The Future Landscape of Bio-Imaging

In summary, the trajectory of bio-imaging is steering toward a future that is marked by technological integration, strategic segmentation, and robust regional dynamics. The insights gleaned from advanced imaging systems, segmented analyses across technology, product, modality, application, and end user, display a market that is thriving on innovation and collaboration. Through transformative shifts in both hardware and software capabilities, bio-imaging is not only enhancing clinical outcomes but also paving the way for novel research frontiers.

The ongoing evolution in imaging technology and data analytics promises to unlock new possibilities in precision medicine, thereby shaping the future of healthcare delivery on a global scale. As healthcare providers and innovators continue to navigate a landscape defined by rapid change, the need for astute market analysis and proactive strategic planning becomes increasingly apparent. This conclusion underscores the relevance of staying informed about the latest trends and being prepared to take decisive action in a competitive environment.

Ultimately, by embracing a holistic view that merges innovation with practical application, stakeholders can drive meaningful improvements in patient care and clinical research, ensuring that bio-imaging remains at the forefront of medical advancement.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing prevalence of chronic diseases and neurological disorders
    • 5.1.1.2. Global shift toward non-invasive diagnostic methods
    • 5.1.1.3. Rising healthcare expenditure and investments in healthcare infrastructure
  • 5.1.2. Restraints
    • 5.1.2.1. Stringent regulatory standards and interoperability issues of bio-imaging devices and systems
  • 5.1.3. Opportunities
    • 5.1.3.1. Development of portable and affordable bio-imaging devices for use in point-of-care settings
    • 5.1.3.2. Expansion of bio-imaging applications within the neurology and oncology sectors
  • 5.1.4. Challenges
    • 5.1.4.1. Ethical and privacy concerns associated with use of bio-imaging data
• 5.2. Market Segmentation Analysis
  • 5.2.1. Technology: Increasing preference for ultrasound due to its affordability and non-ionizing nature
  • 5.2.2. End User: Expanding usage of bio-imaging by diagnostic imaging centers
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Bio-imaging Market, by Technology

• 6.1. Introduction
• 6.2. Endoscopy
• 6.3. Magnetic Resonance Imaging
• 6.4. Nuclear Imaging
• 6.5. Surgical Microscopy
• 6.6. Ultrasound
• 6.7. X-ray Imaging

7. Bio-imaging Market, by Product

• 7.1. Introduction
• 7.2. Imaging Systems
• 7.3. Instruments
  • 7.3.1. CT Scanners
  • 7.3.2. MRI Machines
  • 7.3.3. Ultrasound Devices
• 7.4. Reagents
• 7.5. Software
  • 7.5.1. Data Management Software
  • 7.5.2. Image Analysis Software

8. Bio-imaging Market, by Modality

• 8.1. Introduction
• 8.2. 2D Imaging
• 8.3. 3D Imaging

9. Bio-imaging Market, by Application

• 9.1. Introduction
• 9.2. Clinical Diagnostics
• 9.3. Drug Discovery
• 9.4. Research
• 9.5. Therapeutics

10. Bio-imaging Market, by End User

• 10.1. Introduction
• 10.2. Ambulatory Surgical Centers
• 10.3. Diagnostic Imaging Centers
• 10.4. Hospitals & Clinics

11. Americas Bio-imaging Market

• 11.1. Introduction
• 11.2. Argentina
• 11.3. Brazil
• 11.4. Canada
• 11.5. Mexico
• 11.6. United States

12. Asia-Pacific Bio-imaging Market

• 12.1. Introduction
• 12.2. Australia
• 12.3. China
• 12.4. India
• 12.5. Indonesia
• 12.6. Japan
• 12.7. Malaysia
• 12.8. Philippines
• 12.9. Singapore
• 12.10. South Korea
• 12.11. Taiwan
• 12.12. Thailand
• 12.13. Vietnam

13. Europe, Middle East & Africa Bio-imaging Market

• 13.1. Introduction
• 13.2. Denmark
• 13.3. Egypt
• 13.4. Finland
• 13.5. France
• 13.6. Germany
• 13.7. Israel
• 13.8. Italy
• 13.9. Netherlands
• 13.10. Nigeria
• 13.11. Norway
• 13.12. Poland
• 13.13. Qatar
• 13.14. Russia
• 13.15. Saudi Arabia
• 13.16. South Africa
• 13.17. Spain
• 13.18. Sweden
• 13.19. Switzerland
• 13.20. Turkey
• 13.21. United Arab Emirates
• 13.22. United Kingdom

14. Competitive Landscape

• 14.1. Market Share Analysis, 2024
• 14.2. FPNV Positioning Matrix, 2024
• 14.3. Competitive Scenario Analysis
  • 14.3.1. UCSF and GE HealthCare collaborate to advance bio-imaging innovations in brain health and oncology
  • 14.3.2. Nikon strengthens European bio-imaging capabilities with expansion of BioImaging Labs to boost drug discovery efforts
  • 14.3.3. Strategic partnership between MARS Bioimaging and Linkoping University sets new standards in photon-counting CT technology advancement
  • 14.3.4. UK and India Unite to Tackle Big Data Challenges for Groundbreaking Telescope Project
  • 14.3.5. HSS and MARS Bioimaging Collaborate to Revolutionize Musculoskeletal Imaging with Advanced Photon-Counting CT Technology from CERN
• 14.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. BaySpec, Inc.
• 2. Bracco S.p.A.
• 3. Bruker Corporation
• 4. Canon Medical Systems Corporation
• 5. Digirad Corporation
• 6. Esaote S.p.A
• 7. Fujifilm Holdings Corporation
• 8. GE HealthCare Technologies, Inc.
• 9. Hitachi Medical Corporation
• 10. HT BioImaging Ltd
• 11. iThera Medical GmbH
• 12. Kitware, Inc.
• 13. Koninklijke Philips N.V.
• 14. Lantheus Medical Imaging, Inc.
• 15. M Squared Lasers Ltd.
• 16. MARS Bioimaging Limited
• 17. Medtronic PLC
• 18. MobileODT Ltd by Liger Medical LLC
• 19. Perspectum Ltd.
• 20. Quibim, S.L.
• 21. RadNet, Inc.
• 22. Rivanna Medical, Inc.
• 23. Samsung Medison Co., Ltd.
• 24. Siemens Healthineers